US20190142403A1 - Tissue closure device - Google Patents
Tissue closure device Download PDFInfo
- Publication number
- US20190142403A1 US20190142403A1 US16/190,694 US201816190694A US2019142403A1 US 20190142403 A1 US20190142403 A1 US 20190142403A1 US 201816190694 A US201816190694 A US 201816190694A US 2019142403 A1 US2019142403 A1 US 2019142403A1
- Authority
- US
- United States
- Prior art keywords
- tissue
- tissue layer
- anchors
- housing
- vascular closure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000002792 vascular Effects 0.000 claims abstract description 91
- 238000000034 method Methods 0.000 claims abstract description 39
- 210000004204 blood vessel Anatomy 0.000 claims description 25
- 239000003106 tissue adhesive Substances 0.000 claims description 18
- 230000004323 axial length Effects 0.000 claims description 9
- 229910052751 metal Inorganic materials 0.000 claims description 6
- 239000002184 metal Substances 0.000 claims description 6
- 229920001651 Cyanoacrylate Polymers 0.000 claims description 4
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 claims description 4
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 2
- 239000000155 melt Substances 0.000 claims description 2
- 239000004830 Super Glue Substances 0.000 claims 1
- FGBJXOREULPLGL-UHFFFAOYSA-N ethyl cyanoacrylate Chemical compound CCOC(=O)C(=C)C#N FGBJXOREULPLGL-UHFFFAOYSA-N 0.000 claims 1
- 230000023597 hemostasis Effects 0.000 abstract 2
- 210000003195 fascia Anatomy 0.000 description 56
- 210000001367 artery Anatomy 0.000 description 17
- 230000007246 mechanism Effects 0.000 description 17
- 239000012528 membrane Substances 0.000 description 11
- 210000001105 femoral artery Anatomy 0.000 description 5
- 239000000463 material Substances 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 239000012858 resilient material Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 238000013131 cardiovascular procedure Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 210000000109 fascia lata Anatomy 0.000 description 1
- 210000003099 femoral nerve Anatomy 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12009—Implements for ligaturing other than by clamps or clips, e.g. using a loop with a slip knot
- A61B17/12013—Implements for ligaturing other than by clamps or clips, e.g. using a loop with a slip knot for use in minimally invasive surgery, e.g. endoscopic surgery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/122—Clamps or clips, e.g. for the umbilical cord
- A61B17/1227—Spring clips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00349—Needle-like instruments having hook or barb-like gripping means, e.g. for grasping suture or tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/0065—Type of implements the implement being an adhesive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/00663—Type of implements the implement being a suture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00646—Type of implements
- A61B2017/00668—Type of implements the implement being a tack or a staple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00672—Locating means therefor, e.g. bleed back lumen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00676—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect promotion of self-sealing of the puncture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00778—Operations on blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00862—Material properties elastic or resilient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00831—Material properties
- A61B2017/00867—Material properties shape memory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0409—Instruments for applying suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0427—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors having anchoring barbs or pins extending outwardly from the anchor body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/06—Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
- A61B17/06166—Sutures
- A61B2017/0619—Sutures thermoplastic, e.g. for bonding, welding, fusing or cutting the suture by melting it
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B2017/12004—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord for haemostasis, for prevention of bleeding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/28—Surgical forceps
- A61B17/29—Forceps for use in minimally invasive surgery
- A61B2017/2901—Details of shaft
- A61B2017/2906—Multiple forceps
Definitions
- a catheter In many percutaneous cardiovascular procedures, a catheter is inserted into an artery, such as the femoral artery, through a percutaneous vascular access.
- the catheter may be inserted, typically over a guidewire, directly into an artery (a “bareback” procedure), or the catheter may be inserted through a vascular introducer.
- the physician removes the catheter and then removes the introducer from the vessel (if one was used). The physician then must prevent or limit the amount of blood that leaks through the vascular access.
- Physicians currently use a number of methods to close the vascular access, such as localized external compression, suture-mediated closure devices, plugs, gels, foams and similar materials.
- closure procedures may be time consuming, and may consume a significant portion of the time of the procedure.
- existing methods are associated with complications such as hematoma or thromboses.
- some of such procedures, particularly suture-mediated closure devices are known to have high failure rates in the presence of common vascular disease such as atherosclerosis and calcification.
- a vascular closure device may include a housing having an elongate configuration with an axial length greater than a transverse dimension thereof. Such a housing may further include a proximal end, a distal end and a distal section.
- a plurality of anchor deployers are slidably disposed within the housing adjacent each other at the distal section of the housing and are configured to extend and spread from the distal section of the housing.
- Each of the anchor deployers may include a deployment rod which is slidably disposed relative to the housing and which includes an elongate resilient configuration.
- Each deployment rod may also include a distal end that extends distally and radially from the distal section of the housing so as to spread out from other deployment rod distal ends.
- each anchor deployer may also include an anchor which is secured to the distal end of the deployment rod and which is configured to grip tissue such as the tissue of a fascia tissue layer.
- the vascular closure device embodiment may further include a tissue grip which is deployable from the distal end of the housing.
- Some embodiments of a method for vascular closure may include disposing a distal end of the housing of the vascular closure device to a position adjacent the passage in the tissue layer and deploying a plurality of anchor deployers from a distal section of the housing.
- the anchor deployers may be so deployed by distally advancing deployment rods of the anchor deployers in a distal and radially outward direction from the housing into the tissue layer in positions disposed about the passage in the tissue layer.
- Respective anchors of the anchor deployers may then be secured to the tissue layer in positions disposed about the passage in the tissue layer.
- the deployment rods may then be proximally retracted back into the distal section of the housing so as to draw the anchors and respective tissue layer portions secured thereto together adjacent the distal section of the housing to gather the tissue and close the passage in the tissue layer. Thereafter, a tissue grip may be deployed over the anchors and onto the tissue layer portions gathered and secured to the anchors so as to secure the tissue layer portions together with the access hole closed or reduced. The anchors may then be released from the tissue layer portions which are secured together.
- Some embodiments of a method for vascular closure may include disposing a distal end of the housing of the vascular closure device to a position adjacent the passage in the tissue layer and deploying a plurality of anchor deployers from a distal section of the housing.
- the anchor deployers may be so deployed by distally advancing deployment rods of the anchor deployers in a distal and radially outward direction from the housing into the tissue layer in positions disposed about the passage in the tissue layer.
- Respective anchors of the anchor deployers may then be secured to the tissue layer in positions disposed about the passage in the tissue layer.
- the deployment rods may then be proximally retracted back into the distal section of the housing so as to draw the anchors and respective tissue layer portions secured thereto together adjacent the distal section of the housing to gather the tissue and close the passage in the tissue layer. Thereafter, a tissue grip may be deployed over the anchors and onto the tissue layer portions gathered and secured to the anchors so as to secure the tissue layer portions together with the access hole closed or reduced. The anchors may then be detached from each of the respective deployment rods secured thereto and left in the patient secured to the tissue layer.
- Some embodiments of a method for vascular closure may include disposing a vascular closure device adjacent a passage in a tissue layer which is disposed above and adjacent an access hole in a blood vessel of a patient and deploying a plurality of anchors from a distal section of the vascular closure device in a distal and radially outward direction therefrom.
- the method may also include engaging the tissue layer in positions disposed about the passage in the tissue layer with the anchors and securing the anchors to the tissue layer in the positions disposed about the passage in the tissue layer. Thereafter, the anchors may be proximally retracted closer together so as to draw the anchors and respective tissue layer portions secured thereto together thereby closing the passage in the tissue layer.
- a tissue grip may then be deployed onto the tissue layer portions drawn together by the anchors so as to secure the drawn together tissue layer portions thereby closing the passage in the tissue layer and achieving vascular closure of the access hole in the blood vessel.
- FIG. 1 schematically exemplifies a first embodiment of a vascular closure device according to a possible embodiment of the present disclosure.
- FIGS. 2A and 2B show a detailed view of the creation of a tissue lock using the vascular closure device.
- FIGS. 2C and 2D illustrate a closure sequence for treatment of an unwanted passage through a wall of a blood vessel without directly engaging the blood vessel.
- FIGS. 3A and 3B conceptually illustrate an engagement member, exemplified as an anchor element.
- FIGS. 4A and 4B illustrate the operation of an anvil member that functions as a deployable positioning feature.
- FIG. 5 is an elevation view of a vascular closure device embodiment.
- FIG. 6 is an enlarged view of the encircled portion 6 - 6 of the vascular closure device embodiment of FIG. 5 .
- FIG. 6A is a front view of the vascular closure device embodiment of FIG. 5 .
- FIG. 7A is an elevation view of a lock ring embodiment.
- FIG. 7B is a top view of the lock ring embodiment of FIG. 7A .
- FIG. 7C shows a top view of the lock ring embodiment of FIG. 7A in a radially expanded state.
- FIG. 7D is a transverse cross section of the lock ring embodiment of FIG. 7B taken along lines 7 D- 7 D of FIG. 7B .
- FIG. 8A is an elevation view of a lock ring embodiment.
- FIG. 8B is a top view of the lock ring embodiment of FIG. 8A .
- FIG. 8C is a top view of the lock ring embodiment of FIG. 8A in a radially expanded state.
- FIG. 9 is an elevation view of a releasable anchor embodiment in a closed state.
- FIG. 10 is an elevation view of the releasable anchor embodiment of FIG. 9 in an open state.
- FIG. 10A is a transverse cross section of the deployment rod of FIG. 10 taken along lines 10 A- 10 A of FIG. 10 .
- FIG. 11 is an elevation view of a releasable anchor embodiment in a straightened state.
- FIG. 12 is an elevation view of the releasable anchor embodiment of FIG. 11 in a curved, tissue gripping state.
- FIG. 12A is a transverse cross section of a deployment rod embodiment of FIG. 12 taken along lines 12 A- 12 A of FIG. 12 .
- FIG. 13 is an elevation view of a detachable anchor embodiment.
- FIG. 13A is an enlarged view of the encircled portion 13 A- 13 A of the detachable anchor embodiment of FIG. 13 .
- FIG. 13B is a transverse cross section of the deployment rod embodiment of FIG. 13 taken along lines 13 B- 13 B of FIG. 13 .
- FIG. 14 is an elevation view of a detachable anchor embodiment.
- FIG. 14A is a transverse cross section of the deployment rod embodiment of FIG. 14 taken along lines 14 A- 14 A of FIG. 14 .
- FIG. 15 is an elevation view in partial section of a distal section of a housing of a vascular closure device disposed adjacent an access hole of a fascia tissue layer.
- FIG. 16 shows the vascular closure device of FIG. 15 with the anchor deployers distally extended and with anchors thereof secured to the fascia tissue layer.
- FIG. 16A shows the releasable anchor embodiment of FIG. 9 in a closed state and secured to fascia tissue.
- FIG. 16B shows the releasable anchor embodiment of FIG. 11 in a curved tissue gripping state secured to fascia tissue.
- FIG. 16C shows the detachable anchor embodiment of FIG. 14 disposed in and secured to fascia tissue.
- FIG. 16D shows the detachable anchor embodiment of FIG. 13 disposed in and secured to fascia tissue.
- FIG. 17 shows the anchor deployers of the vascular closure device of FIG. 16 being proximally retracted and closing the access passage in the fascia tissue layer.
- FIG. 18 is an elevation view in partial section showing the lock ring being deployed from the distal end of the housing of the vascular closure device of FIG. 5 .
- FIG. 19 shows the lock ring of FIG. 18 disposed around and securing portions of the fascia tissue layer gathered by the anchors of the vascular closure device of FIG. 5 .
- FIG. 20 shows portions of the fascia tissue layer disposed about the access hole in a gathered and secured state with the lock ring and tissue adhesive disposed thereon.
- FIG. 21 shows portions of the fascia tissue layer disposed about the access hole in a gathered and secured state with tissue adhesive only disposed thereon.
- FIG. 22 shows portions of the fascia tissue layer disposed about the access hole in a gathered and secured state with the lock ring disposed thereon, the lock ring being further secured in fixed relation to the portions of fascia tissue by detachable anchors which are secured to the fascia tissue above the lock ring which may be mechanically captured by the deployed detachable tissue anchors.
- FIG. 23 shows a lock ring embodiment in a relaxed self-constrained state disposed about and securing portions of gathered fascia tissue layer.
- FIG. 24 shows upward and inward facing barb embodiments of the lock ring embodiment of FIG. 23 penetrating into gathered tissue of the portions of fascia tissue layer and mechanically preventing upward movement of the lock ring relative to the fascia tissue.
- a hole in the form of an access passage or the like may be left in a major vessel at an access site that must be closed.
- Methods for percutaneous closure of such a hole may include remote suturing of the vessel, plugging the hole, and remote suturing of the fascia adjacent to the vessel.
- Certain device and method embodiments discussed herein are directed to mechanical closure of an access passage in the fascia tissue layer adjacent to an access hole in a vessel such as an artery or vein of a patient. Some of these embodiments may also be applicable to direct closure of an arterial wall in some instances.
- Some vascular closure device and method embodiments discussed herein may provide a robust and easy-to-use device for closing a vascular access hole after a minimally invasive procedure.
- vascular closure device embodiments discussed herein may be useful for closing large vascular access holes.
- certain vascular closure device and method embodiments are discussed in U.S. patent application Ser. No. 15/277,542, filed Sep. 27, 2016, by Thomas Larzon, et al., entitled VASCULAR CLOSURE DEVICE, which is incorporated by reference in its entirety.
- FIGS. 1-4B The following discussion of the device and method embodiments of FIGS. 1-4B is directed generally to closure of a vascular access passage as well as axial positioning of certain portions of vascular closure device embodiments during such a closure procedure. Such axial positioning devices and methods may be applied to and used with any appropriate vascular closure device or method of embodiment discussed herein.
- FIG. 1 an embodiment of a vascular closure device 10 is introduced percutaneously over a guide wire 8 into a blood vessel/artery 5 , through the skin 1 and the fascia lata 2 of a patient.
- An optional anvil member 9 may be arranged inside the blood vessel 5 to create a reference point along an axial orientation to the engagement members 11 and/or for controlling bleeding from an inner lumen of the artery 5 .
- the engagement members 11 may then be placed and released through the vascular closure device 10 and may attach to fascia tissue 3 proximate to the blood vessel 5 and may involve the fascia membrane 3 (fascia iliacus), but, in some instances, not a wall 22 of the blood vessel 5 .
- the engagement members 11 may for example be pushed out of the vascular closure device 10 and into the fascia membrane 3 using deployment members provided as pusher rods 12 arranged in independent lumens provided with the vascular closure device 10 , for example through a pusher assembly in a common lumen that simultaneously deploys all engagement members 11 , through a spring-loaded mechanism or the like.
- the engagement members 11 may be connected with a single filament such as a suture or a plurality of filaments or sutures 13 .
- a femoral vein 4 there is further shown a femoral vein 4 , a femoral nerve 6 and adjacent/interstitial tissues 7 .
- the suture 13 may for example be routed through each of the engagement members 11 in sequence.
- one suture 13 may be looped through each of the engagement members 11 in sequence, or a separate suture 13 may be attached to each engagement member 11 .
- the tissue e.g. fascia membrane 3
- the tissue may then pulled together in a radially inward direction towards an access passage in the fascia layer 3 with the suture 13 connected to the engagement members 11 .
- the tissue/fascia membrane 3 is tightened towards the center and the access passage therethrough and may then create a tissue lock, thereby indirectly sealing the access hole in the artery 5 .
- the anvil member 9 may be removed from the artery 5 .
- FIGS. 2C and 2D an embodiment of a vascular closure sequence is shown whereby a passage through a wall 22 of the vessel 5 such as the blood vessel shown is treated such that leakage of blood from the interior volume of the blood vessel (not shown) is slowed or stopped to a clinically acceptable degree.
- a passage in the wall of the blood vessel specifically, the femoral artery 5
- the fascia tissue layer 3 disposed proximate to an outer surface of the femoral artery 5 is the fascia iliacus 3 .
- the phrase “in general alignment” as applied to the respective passages may mean at least that an appropriately sized elongate device such as a catheter or sheath may pass through both passages without significant relative lateral displacement between the tissue 3 and artery 5 .
- the tissue layer 3 may be disposed sufficiently proximate the outside surface of the blood vessel 5 such that gathering and approximation of the fascia tissue 3 which is disposed about the passage through the tissue 3 so as to close the passage through the tissue/fascia membrane 3 and form a tissue lock is sufficient to tighten and displace the closed gathered tissue/fascia membrane 3 against the outer surface of the artery 5 which is adjacent the passage through the artery 5 as shown in FIG. 2D .
- an inner surface of the tissue layer 3 disposed proximate to the outer surface of the blood vessel 5 may be separated from the outer surface of the blood vessel in the region of the respective passages therethrough by a distance of up to about 10 mm, more specifically, up to about 5 mm.
- FIGS. 3A and 3B there is conceptually illustrated an engagement member, exemplified as an anchor element 15 .
- the anchor element 15 is shown as initially deployed, so that it slides easily in the direction away from a deployment point.
- the deployment point may optionally be deflected toward the tissue/fascia membrane 3 to promote engagement.
- FIG. 3B shows the anchor element 15 after motion has been reversed toward the deployment point, and the anchor element 15 has embedded into the tissue/fascia membrane 3 . That is, a tip 17 of the anchors element 15 is in one embodiment hook-shaped, so that it easily slides outward without engaging the tissue/fascia membrane 3 .
- the tip 17 of the anchor element 15 is adapted to mechanically engage with the tissue/fascia membrane 3 .
- FIGS. 4A and 4B conceptually illustrate the operation of an anvil member exemplified as a deployable positioning feature 20 .
- deployable positioning feature 20 may be inserted through the wall 22 and into the interior volume of the blood vessel, such as the femoral artery 5 .
- the deployable positioning feature 20 may be structured similar to an umbrella (using a mesh material), where the deployable positioning feature 20 in a radially collapsed form may be inserted into the artery 5 .
- the deployable positioning feature 20 Once within the artery 5 , with further reference to FIG.
- the deployable positioning feature 20 may be “unfolded” and radially expanded from the collapsed form such that a total surface area proximate to the longitudinal axis of the deployable positioning feature 20 is increased and thus may be retracted towards the interior wall of the artery 5 . Accordingly, a reference point may be thereby established for further operation of the vascular closure device 10 .
- a mechanical “grabber” type device may be used to grab the fascia tissue layer 3 around an access hole 25 in the fascia (see FIG. 15 ), pull it together, and apply a tissue grip type of device such as lock ring 27 or other tissue grip type retention mechanism such as a tissue adhesive 30 directly to the tissue of the fascia 3 to secure the gathered fascia tissue 32 disposed around the access hole 25 in the closed position to form a tissue lock and achieve vascular closure of an access hole in the adjacent vessel 5 .
- FIGS. 5-24 illustrate embodiments of such grabber-type vascular closure devices 24 .
- the arms also referred to herein as anchor deployers 26 , may be initially retracted into a housing 28 to achieve a low profile. Once in place above the fascia tissue layer 3 , the arms 26 may be extended distally and radially outward. Due to their preformed curved shape formed from an elastic resilient material (such as stainless steel or nitinol), the arms 26 may be configured to spread out into a radially dispersed pattern disposed around the access hole 25 in the fascia tissue layer 3 .
- an elastic resilient material such as stainless steel or nitinol
- the arms 26 may then engage the fascia tissue layer 3 at two or more points around the access hole 25 .
- This engagement may be accomplished by an anchor 31 such as a small jaw 34 or the like mounted on the distal end 36 of a deployment rod 38 of each arm 26 and adapted to grab the fascia 3 , or a small hook 15 , 40 (see FIGS. 3A and 12 ) could be used to engage the fascia 3 .
- Other similar mechanisms may also be used.
- the housing 28 may be advanced down over the arms 26 , or the arms retracted proximally into the housing 28 , thereby pulling the distal ends 36 of the arms 26 together in a radially inward and proximal direction, approximating the edges of the fascia tissue layer 3 disposed about the access hole 25 therein, and closing or minimizing the access hole 25 .
- the retention mechanism such as a tissue grip mechanism that holds the approximated edges of the gathered fascia tissue 32 in this gathered configuration, such as the ring or clip 27 , may then be deployed onto the gathered tissue 32 . Thereafter, the arms 26 or anchors 31 disposed thereon may be disengaged from the fascia tissue layer 3 and the vascular closure device 24 withdrawn from the patient. Suitable tissue retention may be accomplished in some cases by use of the elastic resilient coil in the form of a lock ring 27 that is stretched onto the outside of the housing 28 about an outside circumference of the arms 26 or outside of a translation track of the arms 26 .
- the lock ring 27 which may include an elastic and resilient self-contracting lock ring 27 , may be pushed off of the housing 28 by a distal end 42 of a larger, concentric outer tube 44 that lies more proximal over an inner tube 46 of the housing 28 .
- the outer tube 44 may be actuated to advance distally relative to the inside tube 46 and deploy the lock ring 27 by advancing a lock ring actuator lever 47 which may be operatively coupled to the outer tube 44 .
- Such elastic coil embodiments 27 may be made from high strength resilient materials such as stainless steel, nitinol, or the like. Some elastic coil embodiments 27 may also be made from or include bioresorbable and/or biodegradable materials.
- the gathered tissue 32 may be held together by a biocompatible, rapidly curing tissue adhesive, such as cyanoacrylate, dispensed from a distal section 48 of the housing 28 .
- tissue adhesive 30 may be dispensed as the gathered tissue of the fascia tissue layer 3 is coming together, to facilitate the apposition of surfaces containing tissue adhesive 30 , or the tissue adhesive 30 may be dispensed onto the gathered tissue 32 once the tissue is bunched together.
- some embodiments of the vascular closure device 24 may include the housing 28 having an elongate configuration with an axial length greater than a transverse dimension thereof.
- a housing 28 may further include a proximal end 50 , a distal end 52 and a distal section 48 .
- a plurality of anchor deployers 26 are slidably disposed within the housing 28 adjacent each other at the distal section 48 of the housing 28 and are configured to extend and spread from the distal section 48 of the housing 28 .
- Each of the anchor deployers 26 may include the deployment rod 38 which is slidably disposed relative to the housing 28 and which includes an elongate resilient configuration.
- Each deployment rod 38 may also include the distal end 36 that extends distally and radially outward from the distal section 48 of the housing 28 so as to spread out from other the distal ends 36 of the deployment rods 38 . In some cases, the deployment rods 38 may be configured to extend distally at the same time or simultaneously.
- Each anchor deployer 26 may also include the anchor 31 which is secured to the distal end 36 of the deployment rod 38 and which is configured to grip tissue such as the tissue of a fascia tissue layer 3 .
- the vascular closure device embodiment 24 may further include the lock ring 27 which may be deployable from the distal end 52 of the housing 28 .
- the vascular closure device of FIG. 5 includes 4 anchor deployers 26 , however any suitable number of anchor deployers 26 may be used.
- vascular closure device embodiments 24 may include about 2 anchor deployers 26 to about 8 anchor deployers 26 , more specifically, about 3 anchor deployers 26 to about 5 anchor deployers 26 .
- the deployment rod embodiments 38 may a generally flattened cross section profile with a radial transverse dimension that is less than a circumferentially oriented transverse dimension.
- the housing 28 may further include a guidewire lumen 54 extending an axial length thereof and a handle 56 secured to the proximal end 50 of the housing 28 .
- a deployment rod pusher 58 which may optionally be spring loaded with a resilient member such as a spring 60 in either a distally biased or proximally biased direction may be operatively coupled to the deployment rods 38 for actuation thereof.
- a resilient member such as a spring 60 in either a distally biased or proximally biased direction
- deployment rod pusher embodiment 58 which are proximally biased this may correspond to a bias with the deployment rods 38 biased towards a retracted position which may be overcome by manual pressure in a distal direction against the deployment rod pusher 58 .
- the spring such as spring 60 shown in FIG.
- the deployment rod pusher 58 is operatively coupled to respective proximal ends of the deployment rods 38 and optionally configured to extend the deployment rods 38 simultaneously in a distal direction upon actuation.
- a tissue grip mechanism may be disposed on the distal end 52 of the housing 28 around the anchor deployers 26 but generally not in contact with the anchor deployers 26 when in an undeployed state.
- the tissue grip mechanism may be configured to compress and secure gathered tissue portions 32 relative to each other in some cases. For such embodiments, once the tissue grip is deployed from the distal end 52 of the housing 28 over the anchor deployers 26 and respective anchors 31 thereof and onto the tissue which has been gathered and bunched by the proximally retracted anchor deployers 26 , different portions of the gathered tissue are secured in a fixed position relative to each other to form a tissue lock and, in some instances, vascular closure.
- the tissue grip mechanism may include the lock ring 27 disposed about the anchor deployers 26 in the form of a self-retracting coil 27 with a central lumen 62 which may be sized to allow movement of the gathered tissue portions 32 disposed therein while the self-retracting coil 27 is in an expanded state as shown in FIG. 7C .
- the interior surface 64 of the central lumen 62 may be configured to compress and secure the gathered tissue portions 32 relative to each other when in a retracted compressed state as shown in FIGS. 7A, 7B, 20, and 22 .
- embodiments of the tissue grip may include the tissue adhesive 30 that may be dispensed from an outlet port, such as a distal port 66 of the guidewire lumen 54 , in the distal end 52 of the housing 28 as shown in FIGS. 20 and 21 .
- tissue adhesive 30 may include cyanoacrylate, fibrin glue, PEG-based polymers or the like.
- the tissue grip embodiments such as lock ring 27 and tissue adhesive 30 may optionally include a tissue engagement feature that is configured to stick to a surface of the gathered tissue 32 such as with the tissue adhesive 30 forming a bond with the gathered tissue 32 or sharp inner edge 64 of the diamond profiled lock ring 27 mechanically impinging the gathered tissue 32 so as to effectively secure the tissue portions together.
- tissue engagement features may further include features which may be mechanically captured within the gathered tissue 32 such as the barbs 76 of the “castle shaped” lock ring 27 ′ shown in FIG. 8A . The barbs 76 are configured to penetrate the gathered tissue 32 and be mechanically captured thereby as shown in FIG. 24 . All of these tissue engagement feature embodiments may generally be used to keep the tissue grip embodiments from slipping off of the gathered tissue 32 once deployed.
- the anchors 31 may include releasable anchors.
- some releasable anchor embodiments may include the jaw 34 that can be moved between an open state and a closed state, each jaw 34 further including an opposed pair of tissue gripping teeth 68 as shown in the anchor embodiment 31 of FIGS. 9-10A and 16A .
- Such anchors 31 that include a jaw 34 may be actuated by a pull wire 69 or the like that may apply tension to a hinged lever 71 at a proximal end of a hinged jaw portion 73 of the jaw 34 as shown in FIG. 10 .
- the pull wire 69 or any other suitable actuation mechanism may be actuated by an actuation lever 59 which may optionally be disposed on the deployment rod pusher 58 shown in FIG. 5 .
- each of the releasable anchors may have a shaft 70 with an elongate configuration having an axial length greater than an outer transverse dimension of the shaft 70 .
- the releasable anchor 31 may be configured to be actuated between a curved tissue gripping state having the curved distal end 40 as shown in FIG. 12 and a straightened state as shown in FIG. 11 .
- the shaft 70 of the releasable anchor 31 may further include a sharpened distal end 72 which is configured to penetrate tissue such as the fascia tissue layer 3 when pushed distally, sharpened distal end 72 first, into the fascia tissue layer 3 .
- the shaft 70 may be made from or include an optional shape memory metal that can be actuated between the curved tissue gripping state shown in FIG. 16B and the straightened state shown in FIG. 11 .
- the shape memory metal of the shaft 70 may include nickel titanium alloy.
- the shaft 70 may include an optional a bi-metal structure that can be actuated between the curved tissue gripping state and the straightened state.
- detachable anchors at the distal ends 36 of the deployment rods 38 and anchor deployers 26 .
- detachable anchor embodiments 31 are shown wherein the anchor deployers 26 include releasable junctions 74 disposed between each such detachable anchor 31 and respective deployment rod 38 which is secured thereto.
- the detachable anchor embodiments 31 may include a proximally oriented barb 76 , and in some cases, a plurality of proximally oriented barbs 76 .
- the releasable junctions 74 used to detach such detachable anchors 31 may include a releasable junction 74 released by thermal detachment, mechanical detachment or any other suitable detachment mechanism.
- the releasable junction embodiment 74 shown in FIG. 13A includes a tether 78 which secured between the distal end 36 of the deployment rod 38 and anchor 31 and which may be melted by a heater element 80 disposed about the tether 78 .
- the heater element 80 may be actuated by applying electrical power from a power source 82 to the heater element 80 through a first electrically conducting wire 84 and a second electrically conducting wire 86 in electrical communication between the power source 82 and the heater element 80 .
- Some embodiments of the vascular closure devices discussed herein may include a lateral surface configured to extend radially from a distal extension of the housing 28 while the lateral surface is disposed within a blood vessel 5 such as the anvil 9 shown in FIG. 1 and the deployable positioning feature 20 shown in FIGS. 4A and 4B and discussed above.
- a lateral surface 9 , 20 that extends radially may be used to provide a reference point between relative axial positions of the wall 22 of the blood vessel 5 and the anchors 31 prior to deployment of the anchors 31 .
- embodiments of the anchors 31 may be deployed a predetermined axial distance from the wall 22 of the blood vessel 5 as measured from the lateral surface 9 , 20 which is disposed against the wall 22 of the blood vessel 5 .
- some embodiments of a method for vascular closure may include disposing the distal end 52 of the housing 28 of the vascular closure device 24 to a position adjacent the passage 25 in the tissue layer 3 and deploying a plurality of anchor deployers 26 from a distal section 48 of the housing 28 .
- the anchor deployers 26 may be so deployed by distally advancing deployment rods 38 of the anchor deployers 26 in a distal and radially outward direction from the housing 28 into the tissue layer 3 in positions disposed about the passage 25 in the tissue layer 3 .
- Respective anchors 311 of the anchor deployers 26 may then be secured to the tissue layer 3 in positions disposed about the passage 25 in the tissue layer 3 as shown in FIGS. 16A-16B .
- the deployment rods 38 may then be proximally retracted back into the distal section 48 of the housing 28 so as to draw the anchors 31 and respective tissue layer portions secured thereto together adjacent the distal section 48 of the housing 28 to gather the tissue 3 and close the passage 25 in the tissue layer 3 .
- the deployment rods may be withdrawn with a spring or similar mechanism to apply a desired tension, or alternatively may be withdrawn with a lead screw, cam or similar mechanism to withdraw the deployment rods a desired distance independent of required tension.
- a tissue grip mechanism may be deployed over the anchors 31 and onto the tissue layer portions 32 gathered and secured to the anchors 31 so as to secure the tissue layer portions together with the access hole 25 closed or reduced.
- the anchors 31 may then be released from the tissue layer portions which are secured together as shown in FIGS. 20 and 21 . Thereafter, the deployment rods 38 and anchors 31 of each of the plurality of anchor deployers 26 may be proximally withdrawn from respective anchors 31 and into the distal section 48 of the housing 28 .
- This may be particularly useful when the operator is not satisfied with the initial placement of the anchors 31 about the access hole 25 in the tissue layer 3 .
- Such repositioning of the anchors 31 may be repeated as many times as is practical by the operator of the vascular closure device 24 .
- the anchors 31 may include the jaws 34 that can be moved between an open state and a closed state as shown in FIGS. 9-10A .
- securing the jaws 34 of the respective anchors 31 to the tissue layer 3 may include inserting tissue of the tissue layer 3 into the jaws 34 while the jaws 34 are in an open state and then closing the jaws 34 to the closed state to grip the tissue layer between the opposed surfaces of the jaws 34 as shown in FIG. 16A .
- the jaws 34 may include the tissue gripping teeth 68 on the opposed surfaces of the jaws 34 and gripping the tissue 3 between the opposed surfaces of the jaws 34 may include engaging and partially penetrating the tissue layer with the tissue gripping teeth 68 .
- releasing the anchors 31 from the tissue layer portions may include moving the jaws 34 from the closed state to the open state such that the tissue is no longer gripped by the opposed surfaces of the jaws 34 or tissue gripping teeth 68 thereof.
- the anchors 31 may include the shaft 70 which has the sharpened distal end 72 and which has an elongate configuration with an axial length greater than an outer transverse dimension as shown in FIG. 11 .
- the shaft 70 may be configured to be actuated between the curved tissue gripping state as shown in FIG. 12 and the straightened state as shown in FIG. 11 .
- securing such respective anchors 31 to the tissue layer 3 may include inserting the sharpened distal ends 72 of the shaft 70 into the tissue layer 3 with the shaft 70 in a straightened state and actuating the shaft 70 to move the shaft 70 into a curved tissue gripping state about tissue of the fascia tissue layer 3 as shown in FIG. 16B .
- releasing the anchors 31 from the tissue layer portions may include actuating the shafts 70 from the curved tissue gripping state to the straightened state and thereafter proximally retracting the shafts 70 from the tissue layer portions.
- deploying the tissue grip mechanism onto the tissue layer portions may include sliding the self-contracting ring 27 in an expanded state from the distal end 52 of the housing 28 and allowing the self-contracting ring 27 to contact to the relaxed state over the tissue layer portions 3 as shown in FIGS. 20 and 22 .
- the self-contracting ring 27 may optionally include a non-circular cross section, such as a diamond-shaped cross section, to increase friction with the tissue bundle 32 .
- Such a self-contracting ring 27 may also include a self-contracting ring embodiment 27 ′ that includes barbs 76 which point upward and radially inward towards a longitudinal axis longitudinal axis 88 of the self-contracting ring 27 ′ as shown in FIGS. 8A-8 c .
- deploying the tissue grip mechanism onto the gathered tissue 32 of the tissue layer portions 3 may include applying the tissue adhesive 30 , such as cyanoacrylate to the gathered tissue 32 of the tissue layer portions as shown in FIGS. 20 and 21 .
- FIG. 20 shows a tissue grip mechanism combination of the self-contracting ring 27 disposed over the gathered tissue 32 as well as the tissue adhesive 30 disposed thereon and in between different portions of the fascia tissue layer 3 .
- some embodiments of a method for vascular closure may include disposing a distal end 52 of the housing 28 of the vascular closure device 24 to a position adjacent the access passage 25 in the tissue layer 3 and deploying a plurality of anchor deployers 26 from a distal section 52 of the housing 28 .
- the anchor deployers 26 may be so deployed by distally advancing deployment rods 38 of the anchor deployers 26 in a distal and radially outward direction from the housing 28 into the tissue layer in positions disposed about the passage 25 in the tissue layer 3 .
- Respective anchors 31 of the anchor deployers 26 may then be secured to the tissue layer 3 in positions disposed about the passage 25 in the tissue layer 3 as shown in FIGS. 16C-16D .
- the deployment rods 38 may then be proximally retracted back into the distal section 48 of the housing 28 so as to draw the anchors 31 and respective tissue layer portions secured thereto together adjacent the distal section 48 of the housing 28 to gather the tissue 3 and close the passage 25 in the tissue layer 3 .
- the tissue grip embodiment may be deployed over the anchors 31 and onto the tissue layer portions 3 gathered and secured to the anchors 31 so as to secure the tissue layer portions together with the access hole 25 closed or reduced.
- the anchors 31 may then be detached from each of the respective deployment rods 38 secured thereto and left in the patient secured to the tissue layer 3 .
- the anchor deployers 26 may include the releasable junctions 74 disposed between each respective deployment rod 38 and anchor 31 thereof.
- detaching each anchor 31 from the respective deployment rod 38 secured thereto may include heating a tether 78 of the releasable junction 74 until it melts.
- the anchor deployers 26 may be mechanically attached to the anchors 31 via a quarter-turn lock.
- a cam or similar mechanism in the handle 56 may be used to rotate each of the deployment rods 38 a quarter turn or other suitable angular displacement to disengage the deployment rods 38 from their respective anchors 31 .
- Embodiments illustratively described herein suitably may be practiced in the absence of any element(s) not specifically disclosed herein.
- any of the terms “comprising,” “consisting essentially of,” and “consisting of” may be replaced with either of the other two terms.
- the terms and expressions which have been employed are used as terms of description and not of limitation and use of such terms and expressions do not exclude any equivalents of the features shown and described or portions thereof, and various modifications are possible.
- a or “an” can refer to one of or a plurality of the elements it modifies (e.g., “a reagent” can mean one or more reagents) unless it is contextually clear either one of the elements or more than one of the elements is described.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Vascular Medicine (AREA)
- Surgical Instruments (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/190,694 US20190142403A1 (en) | 2017-11-16 | 2018-11-14 | Tissue closure device |
US18/538,926 US20240108321A1 (en) | 2017-11-16 | 2023-12-13 | Tissue closure device |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762587353P | 2017-11-16 | 2017-11-16 | |
US16/190,694 US20190142403A1 (en) | 2017-11-16 | 2018-11-14 | Tissue closure device |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/538,926 Division US20240108321A1 (en) | 2017-11-16 | 2023-12-13 | Tissue closure device |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190142403A1 true US20190142403A1 (en) | 2019-05-16 |
Family
ID=66432918
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/190,694 Abandoned US20190142403A1 (en) | 2017-11-16 | 2018-11-14 | Tissue closure device |
US18/538,926 Pending US20240108321A1 (en) | 2017-11-16 | 2023-12-13 | Tissue closure device |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/538,926 Pending US20240108321A1 (en) | 2017-11-16 | 2023-12-13 | Tissue closure device |
Country Status (2)
Country | Link |
---|---|
US (2) | US20190142403A1 (fr) |
WO (1) | WO2019098922A1 (fr) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10639020B2 (en) | 2015-09-28 | 2020-05-05 | M-V Arterica AB | Vascular closure device |
US11179145B2 (en) | 2017-11-16 | 2021-11-23 | M-V Arterica AB | Collapsible tube for hemostasis |
IT202000020383A1 (it) * | 2020-08-25 | 2022-02-25 | Biodismed S R L | Dispositivo medicale per l’emostasi meccanica dei vasi sanguigni in chirurgia d’urgenza video-assistita |
US11938288B2 (en) | 2019-11-19 | 2024-03-26 | Arterica Inc. | Vascular closure devices and methods |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070083231A1 (en) * | 2005-10-07 | 2007-04-12 | Benjamin Lee | Vascular closure |
US9089311B2 (en) * | 2009-01-09 | 2015-07-28 | Abbott Vascular Inc. | Vessel closure devices and methods |
US9295463B2 (en) * | 2009-10-08 | 2016-03-29 | Covidien Lp | Shape memory fasteners and method of use |
EP2811913B1 (fr) * | 2012-01-24 | 2017-11-01 | St. Jude Medical Puerto Rico LLC | Pointe biorésorbable à faible force de libération |
WO2017019525A1 (fr) * | 2015-07-24 | 2017-02-02 | The Johns Hopkins University | Procédé et dispositif d'acquisition ou de fermeture de tissu |
JP6970084B2 (ja) * | 2015-09-28 | 2021-11-24 | エム−ベー アルテリカ アクティエボラーグ | 血管閉鎖デバイス |
-
2018
- 2018-11-14 WO PCT/SE2018/051173 patent/WO2019098922A1/fr active Application Filing
- 2018-11-14 US US16/190,694 patent/US20190142403A1/en not_active Abandoned
-
2023
- 2023-12-13 US US18/538,926 patent/US20240108321A1/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10639020B2 (en) | 2015-09-28 | 2020-05-05 | M-V Arterica AB | Vascular closure device |
US11723639B2 (en) | 2015-09-28 | 2023-08-15 | Arterica Inc. | Vascular closure device |
US11179145B2 (en) | 2017-11-16 | 2021-11-23 | M-V Arterica AB | Collapsible tube for hemostasis |
US11938288B2 (en) | 2019-11-19 | 2024-03-26 | Arterica Inc. | Vascular closure devices and methods |
IT202000020383A1 (it) * | 2020-08-25 | 2022-02-25 | Biodismed S R L | Dispositivo medicale per l’emostasi meccanica dei vasi sanguigni in chirurgia d’urgenza video-assistita |
EP3960113A1 (fr) * | 2020-08-25 | 2022-03-02 | Biodismed s.r.l | Appareil medicale pour hémostase méchanique de vaisseaux sanguins pendant chirurgie d'urgence assistée à vidéo |
Also Published As
Publication number | Publication date |
---|---|
US20240108321A1 (en) | 2024-04-04 |
WO2019098922A1 (fr) | 2019-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11266389B2 (en) | Body part repositioning apparatus and method | |
US20240108321A1 (en) | Tissue closure device | |
JP7440594B2 (ja) | 組織を牽引するためのシステム、装置、及び関連する方法 | |
EP1463451B1 (fr) | Dispositif de suture endoscopique | |
JP5103465B2 (ja) | 終端のための方法と装置 | |
US11723639B2 (en) | Vascular closure device | |
WO2008144395A2 (fr) | Appareils pour fixer et renfermer une ouverture dans un tissu, et procédés d'utilisation associés | |
US20150238194A1 (en) | Hemostasis devices and methods utilizing mechanical methods | |
US20200129164A1 (en) | Self-expanding hemostatic devices and methods for fascia and vessel passages | |
JP2024061757A (ja) | 組織開口部のための閉鎖装置 | |
US20190142402A1 (en) | Collapsible tube for hemostasis | |
US20130066366A1 (en) | Endoscopic hemostasis closure device and delivery system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: M-V ARTERICA AB, SWEDEN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NYMAN, HENRIK;WHIRLEY, ROBERT G.;LARZON, CECILIA;AND OTHERS;SIGNING DATES FROM 20190220 TO 20190513;REEL/FRAME:049164/0285 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
AS | Assignment |
Owner name: ARTERICA INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:M-V ARTERICA AB;REEL/FRAME:058750/0546 Effective date: 20211228 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCV | Information on status: appeal procedure |
Free format text: NOTICE OF APPEAL FILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |